.png)
.png)
Destination BLA, First Stop IND! Webinar
Our next Cell & Gene Therapy webinar entitled Destination BLA, First Stop IND! Considerations for Designing Your Gene Therapy Preclinical and CMC development strategies will take place on June 14 at 4.00pm GMT/8.00am/11.00am ET.
Come and join us as we discuss the multiple considerations to be taken into account when designing your gene therapy preclinical and CMC development strategies to ensure successful IND submission to allow first patient dosing. Our expert panel Ashley Winslow, Vibhor Gupta, Ph.D. and Linda Randall will share their experiences to help build successful strategies that carefully balance time and cost whilst always ensuring quality to meet regulatory needs.
Our presenters:
By registering once, you will have access to and receive updates for each webinar in the series.
Register for this webinar session below.
For further information on our CGT webinar series including previous on demand recordings please visit this page. Free
Come and join us as we discuss the multiple considerations to be taken into account when designing your gene therapy preclinical and CMC development strategies to ensure successful IND submission to allow first patient dosing. Our expert panel Ashley Winslow, Vibhor Gupta, Ph.D. and Linda Randall will share their experiences to help build successful strategies that carefully balance time and cost whilst always ensuring quality to meet regulatory needs.
Our presenters:
- Key Option Leader: Ashley Winslow PhD, President & Chief Scientific Officer, Odylia Therapeutics
- Vibhor Gupta, PhD, Director – CGT Business Operations at Pharmaron
- Linda Randall PhD, Associate Vice President, Biologics Development, Manufacturing and Control at Pharmaron Gene Therapy
By registering once, you will have access to and receive updates for each webinar in the series.
Register for this webinar session below.
For further information on our CGT webinar series including previous on demand recordings please visit this page. Free